A New Method for the High-Precision Assessment of Tumor Changes in Response to Treatment

• URL: http://arxiv.org/abs/2209.03116v1
• Date: Wed, 7 Sep 2022 13:08:14 GMT
• Title: A New Method for the High-Precision Assessment of Tumor Changes in Response to Treatment
• Authors: P. D. Tar, N. A. Thacker, J.P.B. O'Connor
• Abstract summary: Linear Poisson modelling (LPM) evaluates changes in apparent diffusion co-efficient before and 72 hours after radiotherapy. Analyses were significant for all tumors, equating to a gain in power of 4 fold. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Imaging demonstrates that preclinical and human tumors are heterogeneous, i.e. a single tumor can exhibit multiple regions that behave differently during both normal development and also in response to treatment. The large variations observed in control group tumors can obscure detection of significant therapeutic effects due to the ambiguity in attributing causes of change. This can hinder development of effective therapies due to limitations in experimental design, rather than due to therapeutic failure. An improved method to model biological variation and heterogeneity in imaging signals is described. Specifically, Linear Poisson modelling (LPM) evaluates changes in apparent diffusion co-efficient (ADC) before and 72 hours after radiotherapy, in two xenograft models of colorectal cancer. The statistical significance of measured changes are compared to those attainable using a conventional t-test analysis on basic ADC distribution parameters. When LPMs were applied to treated tumors, the LPMs detected highly significant changes. The analyses were significant for all tumors, equating to a gain in power of 4 fold (i.e. equivelent to having a sample size 16 times larger), compared with the conventional approach. In contrast, highly significant changes are only detected at a cohort level using t-tests, restricting their potential use within personalised medicine and increasing the number of animals required during testing. Furthermore, LPM enabled the relative volumes of responding and non-responding tissue to be estimated for each xenograft model. Leave-one-out analysis of the treated xenografts provided quality control and identified potential outliers, raising confidence in LPM data at clinically relevant sample sizes.

Related papers

• Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging [71.91773485443125]
  Grading plays a vital role in breast cancer treatment planning. The current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. This paper examines using optimized CDI$s$ to improve breast cancer grade prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:48:26Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Deep learning-based auto-segmentation of paraganglioma for growth monitoring [0.0]
  We propose an automated tumor volume measurement method based on a deep learning segmentation model using no-new-UNnet (nnUNet) We assess the performance of the model based on visual inspection by a senior otorhinolaryngologist and several quantitative metrics. Using the created model, and a linking procedure that we propose to track the tumor over time, we show how additional volume measurements affect the fit of known growth functions.
  arXiv  Detail & Related papers  (2024-03-19T14:08:56Z)
• Anatomy-informed Data Augmentation for Enhanced Prostate Cancer Detection [1.6539563017720214]
  We propose a new anatomy-informed transformation that leverages information from adjacent organs to simulate physiological deformations of the prostate. We demonstrate the effectiveness of our augmentation on a dataset of 774 biopsy-confirmed examinations.
  arXiv  Detail & Related papers  (2023-09-07T11:46:59Z)
• Federated Learning Enables Big Data for Rare Cancer Boundary Detection [98.5549882883963]
  We present findings from the largest Federated ML study to-date, involving data from 71 healthcare institutions across 6 continents. We generate an automatic tumor boundary detector for the rare disease of glioblastoma. We demonstrate a 33% improvement over a publicly trained model to delineate the surgically targetable tumor, and 23% improvement over the tumor's entire extent.
  arXiv  Detail & Related papers  (2022-04-22T17:27:00Z)
• Imaging-based histological features are predictive of MET alterations in Non-Small Cell Lung Cancer [1.2885809002769635]
  MET is a proto-oncogene whose activation in non-small cell lung cancer leads to increased cell growth and tumor progression. We investigated the association of cell-morphological features with MET amplifications and MET exon 14 deletions. A predictive model could distinguish MET wild-type from MET amplification or MET exon 14 deletion.
  arXiv  Detail & Related papers  (2022-03-18T17:11:05Z)
• Texture Characterization of Histopathologic Images Using Ecological Diversity Measures and Discrete Wavelet Transform [82.53597363161228]
  This paper proposes a method for characterizing texture across histopathologic images with a considerable success rate. It is possible to quantify the intrinsic properties of such images with promising accuracy on two HI datasets.
  arXiv  Detail & Related papers  (2022-02-27T02:19:09Z)
• Controlling False Positive/Negative Rates for Deep-Learning-Based Prostate Cancer Detection on Multiparametric MR images [58.85481248101611]
  We propose a novel PCa detection network that incorporates a lesion-level cost-sensitive loss and an additional slice-level loss based on a lesion-to-slice mapping function. Our experiments based on 290 clinical patients concludes that 1) The lesion-level FNR was effectively reduced from 0.19 to 0.10 and the lesion-level FPR was reduced from 1.03 to 0.66 by changing the lesion-level cost.
  arXiv  Detail & Related papers  (2021-06-04T09:51:27Z)
• Spectral-Spatial Recurrent-Convolutional Networks for In-Vivo Hyperspectral Tumor Type Classification [49.32653090178743]
  We demonstrate the feasibility of in-vivo tumor type classification using hyperspectral imaging and deep learning. Our best model achieves an AUC of 76.3%, significantly outperforming previous conventional and deep learning methods.
  arXiv  Detail & Related papers  (2020-07-02T12:00:53Z)
• Harvesting, Detecting, and Characterizing Liver Lesions from Large-scale Multi-phase CT Data via Deep Dynamic Texture Learning [24.633802585888812]
  We propose a fully-automated and multi-stage liver tumor characterization framework for dynamic contrast computed tomography (CT) Our system comprises four sequential processes of tumor proposal detection, tumor harvesting, primary tumor site selection, and deep texture-based tumor characterization.
  arXiv  Detail & Related papers  (2020-06-28T19:55:34Z)
• Can tumor location on pre-treatment MRI predict likelihood of pseudo-progression versus tumor recurrence in Glioblastoma? A feasibility study [1.9710567127450678]
  We analyzed 74 pre-treatment Glioblastoma MRI scans with PsP and tumor recurrence. Patients with tumor recurrence showed prominence of their initial tumor in the parietal lobe. Patients with PsP showed a multi-focal distribution of the initial tumor in the frontal and temporal lobes, insula, and putamen.
  arXiv  Detail & Related papers  (2020-06-16T19:49:59Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.